Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to establish a cut off level of platelet inhibition
that separates patients with or without previous stent occlusion with acute clinical onset
while on aspirin and clopidogrel treatment within 6 months after coronary stenting for
coronary artery disease.